Table 1.
The demographic data in identified genetic group and nonidentified genetic group by whole-exome sequencing (WES) are demonstrated.
| Clinical Data (N) | Identified Genetic Group (N = 24) |
Nonidentified Genetic Group (N = 30) |
|
|---|---|---|---|
| Symptoms | NS | ||
| Seizures (45) | 20 (44%) | 25 (56%) | |
| No seizure (9) | 4 (44%) | 5 (56%) | |
| Age at first seizure onset | NS | ||
| 0–1 month (10) | 5 (50%) | 5 (50%) | |
| 1 month–2 years (31) | 13 (42%) | 18 (58%) | |
| >2 years (4) | 2 (50%) | 2 (50%) | |
| No seizure (8) | 4 (44%) | 5 (56%) | |
| Sex | p < 0.05 ※ | ||
| Male (30) | 17 (57%) | 13 (43%) | |
| Female (24) | 7 (29%) | 17 (71%) | |
| Number of antiepileptic drugs at the time of study | NS | ||
| 0 (8) | 4 (44%) | 5 (56%) | |
| 1 (10) | 2 (20%) | 8 (80%) | |
| 2 (11) | 5 (49%) | 6 (51%) | |
| >3 or =3 (25) | 13 (54%) | 11 (46%) |
NS indicates not significant. ※ Odds ratio = 3.18 (95% confidence interval = 1.04 to 9.70).